Xiaocai Zhang

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Xiaoying Gao

> Home > Persons > Xiaocai Zhang

Publications

2019
[j3]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/bmcbi/ZhengPZZGL19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/ZhengPZZGL19
Yi Zheng, Hui Peng, Xiaocai Zhang, Zhixun Zhao, Xiaoying Gao, Jinyan Li:
DDI-PULearn: a positive-unlabeled learning method for large-scale prediction of drug-drug interactions. BMC Bioinform. 20-S(19): 661 (2019)
[j2]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/bmcbi/ZhengPZZGL19a
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcbi/ZhengPZZGL19a
Yi Zheng, Hui Peng, Xiaocai Zhang, Zhixun Zhao, Xiaoying Gao, Jinyan Li:
Old drug repositioning and new drug discovery through similarity learning from drug-target joint feature spaces. BMC Bioinform. 20-S(23): 605 (2019)
2018
[c2]
- view
  authority control:
- export record
  dblp key:
  - conf/ijcnn/ZhengPZGL18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/ijcnn/ZhengPZGL18
Yi Zheng, Hui Peng, Xiaocai Zhang, Xiaoying Gao, Jinyan Li:
Predicting Drug Targets from Heterogeneous Spaces using Anchor Graph Hashing and Ensemble Learning. IJCNN 2018: 1-7

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.